Osborne Clarke advised Earlybird, Merieux Equity Partners and NRW.BANK on the deal. Prothea Technologies (Prothea), a private medical technology company spun-out of the Universities of Edinburgh...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised UCL Technology Fund on the investment. Bloomsbury Genetic Therapies Limited (“Bloomsbury”), a clinical-stage biotechnology company developing potentially curative treatments for patients suffering from...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised LDC on its investment in Sohonet, advised by Goodwin Proctor. LDC’s investment will support the existing management team, led by CEO Chuck...
You must be a Standard 1 Year member to access this content.
